日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b(+) Bregs thereby overcoming melanoma PD1-resistance

RAS/MEK/PI3K通路抑制通过靶向CD11b(+) Bregs增强对CD40激动剂的反应,从而克服黑色素瘤PD1耐药性。

Yan, Chi; Luo, Weifeng; Yang, Jinming; Yang, Jing; Chen, Sheau-Chiann; Bergdorf, Kensey; Hu, Qianni; Weiss, Vivian L; Johnson, Douglas B; Liu, Qi; Richmond, Ann

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

定义经导管三尖瓣介入治疗的最佳结果:来自 Tri-QOL 研究的结果

Arnold, Suzanne V; Spertus, John A; Gosch, Kensey; Dunlay, Shannon M; Olds, Danielle M; Jones, Philip G; Kar, Saibal; Wu, Changfu; Cohen, David J

Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care

钠-葡萄糖协同转运蛋白2抑制剂在美国门诊心血管护理中用于治疗心力衰竭

El Rafei, Abdelghani; Gosch, Kensey; Manning, Evan S; Ghajar, Alireza; Raghavan, Sridharan; Maddox, Thomas M; Peterson, Pamela N; Fleming, Lisa; Arnold, Suzanne V; Chan, Paul S; Greene, Stephen J; Fonarow, Gregg C; Jones, Philip G; Allen, Larry A; Hess, Paul L

Accountable Care Organization Participation and Cardiovascular Care Quality

责任医疗组织参与和心血管护理质量

Spatz, Erica S; Oddleifson, D August; Kayani, Jehanzeb; Gosch, Kensey L; Jones, Philip G; Doshi, Rushabh H; Maddox, Thomas M; Desai, Nihar R

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

达格列净治疗伴或不伴2型糖尿病的COVID-19住院患者的疗效和安全性:DARE-19随机试验的预设分析

Abdel Jawad, Mohammad; Furtado, Remo H M; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Langkilde, Anna Maria; Ambery, Philip; Patel, Shachi; Gosch, Kensey; Windsor, Sheryl L; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Javaheri, Ali; Saraiva, J F Kerr; Maia, Lilia Nigro; Berwanger, Otavio; Sauer, Andrew J; Kosiborod, Mikhail N

Abstracts from the Society for Research into Hydrocephalus and Spina Bifida Annual Conference Meeting 4th-6th September 2024, Manchester, United Kingdom

2024年9月4日至6日,英国曼彻斯特,脑积水和脊柱裂研究学会年会摘要

Sauer, Andrew J; Sherrod, Charles F; Gosch, Kensey L; Arnold, Suzanne V; Reaney, Matthew; Zhong, Yue; Lam, Jenny; Wyrwich, Kathleen W; Spertus, John A

The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association Class

堪萨斯城心肌病问卷与纽约心脏协会分级的关系

Sherrod, Charles F 4th; Spertus, John A; Gosch, Kensey L; Wang, Andrew; Elliott, Perry M; Lakdawala, Neal K; Reaney, Matthew; Zhong, Yue; Lam, Jenny; Wyrwich, Kathleen W; Sauer, Andrew J

Health status outcomes after acute myocardial infarction in patients without standard modifiable risk factors

急性心肌梗死后无标准可改变危险因素患者的健康状况结局

Ikemura, Nobuhiro; Chan, Paul S; Gosch, Kensey; Nguyen, Dan D; Iv, Charles F Sherrod; Khan, Mirza; Lu, Yuan; Sawano, Mitsuaki; Krumholz, Harlan M; Spertus, John A

Temporal trends and hospital variation in post-resuscitation fever for in-hospital cardiac arrest

院内心脏骤停复苏后发热的时间趋势和医院间差异

Abdel Jawad, Mohammad; Spertus, John A; Gosch, Kensey L; O'Keefe, Evan; Ikemura, Nobuhiro; Chan, Paul S

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation

堪萨斯城心肌病问卷在三尖瓣反流患者中的验证

Arnold, Suzanne V; Spertus, John A; Gosch, Kensey; Dunlay, Shannon M; Olds, Danielle M; Jones, Philip G; Bocell, Fraser D; Wu, Changfu; Cohen, David J